Clinical Trials

Title   A Phase 3, Randomized, Global Trial of Nivolumab and Epacadostat with Platinum Doublet Chemotherapy versus Platinum Doublet Chemotherapy in First-line Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)
Description   The purpose of this study is to evaluate the efficacy and safety of the combination of nivolumab plus epacadostat in combination with platinum chemotherapy compared with platinum chemotherapy alone, in participants with treatment-na├»ve Stage 4 or recurrent non-small cell lung cancer (NSCLC).
IRB Number   18-013
Treatment   Oncology - Lung Cancer
Status   Active
Start Date   01/09/2018
Principal Name   Moh'd Khushman M.D.
Contact Name   Kathleen Ollis

Email Newsletters

Connect With Us